Skip to main content

Table 1 Sample characteristics

From: Illness perceptions, fear of progression and health-related quality of life during acute treatment and follow-up care in paediatric cancer patients and their parents: a cross-sectional study

 

Acute treatment (n = 46)

Follow-up care (n = 84)

Children

 Gender (n, %)

  

  Male

17 (37.0)

53 (63.1)

  Female

29 (63.0)

31 (36.9)

  Diverse

0 (0.0)

0 (0.0)

 Age (M, SD)

10.6 (3.8)

12.6 (3.3)

 Diagnosis (n, %)

  

  Leukaemia

15 (32.6)

32 (38.1)

  Lymphoma

7 (15.2)

10 (11.9)

  Tumour of the central nervous system

8 (17.4)

24 (28.6)

  Other solid tumour†

16 (34.8)

18 (21.4)

 Time since diagnosis in months (M, SD)

7.6 (17.4)

79.7 (44.0)

 Treatment modality (n, %—multiple responses possible)

  

  Chemotherapy

41 (89.1)

73 (86.9)

  Radiotherapy

7 (15.2)

21 (25.0)

  Surgical measures

21 (45.7)

37 (44.0)

  Haematopoietic stem cell transplant

1 (2.2)

8 (9.5)

  Other‡

0 (0.0)

5 (5.9)

 Combination of treatment modalities

  

  Unimodal

27 (58.7)

46 (54.8)

  Multimodal (more than one modality)

19 (41.3)

38 (45.2)

Parent

 Participating parent (n, %)

  

  Mother

40 (87.0)

69 (82.1)

  Father

6 (13.0)

15 (17.9)

 Age (M, SD)

38.3 (5.8)

42.7 (6.1)

  1. †e.g., Ewing sarcoma, Hepatoblastoma
  2. ‡e.g., immune therapy, proton beam irradiation